A second stimulus originated from the introduction of PSMA targeting ligands for diagnosis and therapy in prostate cancer.3 [68Ga]Ga ‐PSMA ‐114 has proven to be a highly sensitive and specific marker for early detection and localization of prostate lesions in the biochemical recurrence stage and other clinical indications. This evidence concerns the gene FOLH1 and Familial prostate cancer.